Note: Dr. Steinman received the prestigious 2007 Albert Lasker Award for Basic Medical Research for the discovery of dendritic cells. The award committee called him “a scientific sleuth, who without cloak and dagger, uncovered the intelligence-gathering component of our immune system—a monumental achievement in the 200-year history of immunology.” Dr. Steinman came to Baylor on September 20, 2007, as part of the celebration of the tenth anniversary of the Baylor Institute for Immunology Research (Figure (Figure11). We were honored to welcome him and appreciate his willingness to publish his well-received presentation in Proceedings. Figure 1 Ralph M. Steinman, MD, with Jacques Banchereau, PhD, director of the Baylor Institute for Immunology Research. —Michael a. e. Ramsay, MD, associate editor and president of Baylor Research Institute Immunology plays an important role in many clinical conditions. In some instances—such as infectious diseases and cancer—the goal is to improve the immune response to the pathogen or challenge; in other instances—such as transplantation, autoimmunity, and allergy—the goal is to reduce the specific immune response. Already, immunology is providing valuable therapies, mainly in the form of monoclonal antibodies. Anti–tumor necrosis factor (TNF) is being used to treat arthritis and other inflammatory diseases, and anti-CD20 is being used to treat B cell lymphoma. However, the T cell limb of the immune response also needs to be harnessed in a disease- or antigen-specific manner in medicine. This opportunity in immunology and medicine is significant because of the way T cells are formed. The immune system is blessed with a superb repertoire of clones (Figure (Figure22). Each clone has a specific receptor for antigen, and within that repertoire are clones specific for microbes, tumors, self, the environment, and so forth—many of the relevant antigens to disease. Thus, the repertoire provides the potential for antigen-specific therapies and vaccines, which will mount a broad-based but specific response to the relevant pathogen, in contrast to cyclosporine, for example, which is a general immunosuppressant. Figure 2 Three elemental R's of T cell biology: repertoire, recognition, response. Reprinted with permission from Nature Medicine (1). One of the main goals in human immunology research is to establish the principles to manipulate these clones in a patient, so that they will expand and carry out the function that is appropriate to a successful therapy. At the Rockefeller University and the Baylor Institute for Immunology Research, one of the main approaches is to try to harness the biology of dendritic cells, which use their tree-like processes or dendrites to constantly probe their environment (Figure (Figure33). Figure 3 Dendritic cells probing the environment in mouse lymphoid tissue. Photomicrograph courtesy of Dr. Juliana Idoyaga; reprinted with permission from Nature Medicine (1).